>
Lexington BioSciences Inc logo

LNB - Lexington BioSciences Inc Share Price

C$0.08 0.0  60.0%

Last Trade - 04/05/20

Sector
Healthcare
Size
Micro Cap
Market Cap £1.38m
Enterprise Value £1.33m
Revenue £n/a
Position in Universe th / 2712
Bullish
Bearish
Unlock LNB Revenue
Momentum
Relative Strength (%)
1m -12.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,Lexington Biosciences Holdings Corp revenues was notreported. Net loss decreased 10% to C$390K. Lower net lossreflects Stock-based compensation decrease of 86% to C$24K(expense), Management fees decrease of 16% to C$109K(expense), Insurance decrease of 55% to C$10K (expense).Basic Earnings per Share excluding Extraordinary Itemsincreased from -C$0.11 to -C$0.08.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LNB Revenue Unlock LNB Revenue

Net Income

LNB Net Income Unlock LNB Revenue

Normalised EPS

LNB Normalised EPS Unlock LNB Revenue

PE Ratio Range

LNB PE Ratio Range Unlock LNB Revenue

Dividend Yield Range

LNB Dividend Yield Range Unlock LNB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LNB EPS Forecasts Unlock LNB Revenue
Profile Summary

Lexington Biosciences Holdings Corp., formerly Lexington Biosciences Inc., is a Canada-based medical device company, which core business is to develop and commercialize non-invasive diagnostic product HeartSentry to monitor cardiovascular health by assessing the function of a person’s vascular endothelium - the vital innermost lining of a person’s cardiovascular system. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The company is in the final stages of releasing the developed product for clinical studies. The Company's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated December 22, 2015
Public Since May 9, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Canadian Securities Exchange
Shares in Issue 27,456,400
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LNB Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LNB
Upcoming Events for LNB
Frequently Asked Questions for Lexington BioSciences Inc
What is the Lexington BioSciences Inc share price?

As of 04/05/20, shares in Lexington BioSciences Inc are trading at C$0.08, giving the company a market capitalisation of £1.38m. This share price information is delayed by 15 minutes.

How has the Lexington BioSciences Inc share price performed this year?

Shares in Lexington BioSciences Inc are currently trading at C$0.08 and the price has moved by -75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lexington BioSciences Inc price has moved by -81.7% over the past year.

What are the analyst and broker recommendations for Lexington BioSciences Inc?

There are no analysts currently covering Lexington BioSciences Inc.

When will Lexington BioSciences Inc next release its financial results?

Lexington BioSciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Lexington BioSciences Inc dividend yield?

Lexington BioSciences Inc does not currently pay a dividend.

Does Lexington BioSciences Inc pay a dividend?

Lexington BioSciences Inc does not currently pay a dividend.

When does Lexington BioSciences Inc next pay dividends?

Lexington BioSciences Inc does not currently pay a dividend.

How do I buy Lexington BioSciences Inc shares?

To buy shares in Lexington BioSciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lexington BioSciences Inc?

Shares in Lexington BioSciences Inc are currently trading at C$0.08, giving the company a market capitalisation of £1.38m.

Where are Lexington BioSciences Inc shares listed? Where are Lexington BioSciences Inc shares listed?

Here are the trading details for Lexington BioSciences Inc:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: LNB
What kind of share is Lexington BioSciences Inc?

We were not able to load our ranking data for Lexington BioSciences Inc

Is there a Lexington BioSciences Inc share price forecast 2021?

We were not able to load any forecast data for Lexington BioSciences Inc.

How can I tell whether the Lexington BioSciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lexington BioSciences Inc. Over the past six months, the relative strength of its shares against the market has been -31.35%. At the current price of C$0.08, shares in Lexington BioSciences Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lexington BioSciences Inc PE Ratio?

We were not able to find PE ratio data for Lexington BioSciences Inc.

Who are the key directors of Lexington BioSciences Inc?

We were unable to find the directors for Lexington BioSciences Inc.

Who are the major shareholders of Lexington BioSciences Inc?

Here are the top five shareholders of Lexington BioSciences Inc based on the size of their shareholding:

Ancora Advisors, L.L.C. Investment Advisor/Hedge Fund
Percentage owned: % (10 shares)
Similar to LNB
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.